Can the new Antimicrobial Resistance Benchmark blaze a new trail?

The Lancet

The Lancet publishes a commentary on the potential of the Access to Medicine Foundation’s forthcoming Antimicrobial Resistance Benchmark to stimulate pharmaceutical companies to address the growing threat of antimicrobial resistance. The commentary has been co-authored by Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation, and Marc Mendelson, Professor of Infectious Diseases and Head of the Division of Infectious Diseases & HIV Medicine, Groote Schuur Hospital, University of Cape Town, South Africa.

Follow us and engage with us on LinkedIn and Twitter.